Insider Trading Alert - APT, RE And BPOP Traded By Insiders - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 29, 2014, 60 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,000.00 to $206,654,400.00.

Highlighted Stocks Traded by Insiders:

Alpha Pro Tech (APT) - FREE Research Report

Hoffman Lloyd, who is CFO and Sr VP Finance and Admi at Alpha Pro Tech, sold 60,000 shares at $4.36 on Oct. 29, 2014. Following this transaction, the CFO and Sr VP Finance and Admi owned 101,000 shares meaning that the stake was reduced by 37.27% with the 60,000-share transaction.

The shares most recently traded at $3.84, down $0.52, or 13.57% since the insider transaction. Historical insider transactions for Alpha Pro Tech go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares sold: 42,500

The average volume for Alpha Pro Tech has been 4.3 million shares per day over the past 30 days. Alpha Pro Tech has a market cap of $71.0 million and is part of the health care sector and health services industry. Shares are up 65.12% year-to-date as of the close of trading on Wednesday.

Alpha Pro Tech, Ltd. is engaged in developing, manufacturing, and marketing a line of disposable protective apparel, building supply products, and infection control products in the United States and internationally. The company has a P/E ratio of 25.9. Currently, there are no analysts who rate Alpha Pro Tech a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on APT - FREE

TheStreet Quant Ratings

rates Alpha Pro Tech as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full

Alpha Pro Tech Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Everest Re Group (RE) - FREE Research Report

Singer Roger M., who is Director at Everest Re Group, sold 668 shares at $166.98 on Oct. 29, 2014. Following this transaction, the Director owned 8,000 shares meaning that the stake was reduced by 7.71% with the 668-share transaction.

The shares most recently traded at $168.76, up $1.78, or 1.05% since the insider transaction. Historical insider transactions for Everest Re Group go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 3,632
  • 24-Week # shares sold: 5,632

The average volume for Everest Re Group has been 296,100 shares per day over the past 30 days. Everest Re Group has a market cap of $7.6 billion and is part of the financial sector and insurance industry. Shares are up 7.47% year-to-date as of the close of trading on Wednesday.

Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products. It operates through the U.S. Reinsurance, Insurance, International, Bermuda, and Mt. Logan Re segments. The U.S. The stock currently has a dividend yield of 1.8%. The company has a P/E ratio of 6.4. Currently, there is 1 analyst who rates Everest Re Group a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RE - FREE

TheStreet Quant Ratings

rates Everest Re Group as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Everest Re Group Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Popular (BPOP) - FREE Research Report

Negron Eduardo J., who is Executive Vice President at Popular, sold 8,500 shares at $31.70 on Oct. 29, 2014. Following this transaction, the Executive Vice President owned 26,695 shares meaning that the stake was reduced by 24.15% with the 8,500-share transaction.

The shares most recently traded at $31.73, up $0.03, or 0.09% since the insider transaction. Historical insider transactions for Popular go as follows:

  • 4-Week # shares sold: 16,507
  • 12-Week # shares sold: 16,507
  • 24-Week # shares sold: 16,507

The average volume for Popular has been 828,200 shares per day over the past 30 days. Popular has a market cap of $3.3 billion and is part of the financial sector and banking industry. Shares are up 11.56% year-to-date as of the close of trading on Wednesday.

Popular, Inc., through its subsidiaries, provides a range of retail and commercial banking products and services primarily to institutional and retail customers in Puerto Rico and the Mainland United States. The company accepts various deposit products. Currently, there are 3 analysts who rate Popular a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BPOP - FREE

TheStreet Quant Ratings

rates Popular as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

Popular Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null